3.83
price down icon4.96%   -0.20
after-market 시간 외 거래: 3.84 0.010 +0.26%
loading

Altimmune Inc 주식(ALT)의 최신 뉴스

pulisher
Jul 29, 2025

Is Altimmune Inc. stock reversal real or fakeReal Trader Watchlist with Entry Targets - Newser

Jul 29, 2025
pulisher
Jul 29, 2025

Is Altimmune Inc. reversing from oversold territoryShort-Term Swing Opportunity Summary Sheet - Newser

Jul 29, 2025
pulisher
Jul 29, 2025

Why Altimmune Inc. stock attracts strong analyst attentionMachine Learning Stock Price Forecast Tool - Newser

Jul 29, 2025
pulisher
Jul 28, 2025

ALT Investor Notice: Levi & Korsinsky Investigates Altimmune, Inc. For Securities Law Violations - ACCESS Newswire

Jul 28, 2025
pulisher
Jul 28, 2025

Altimmune, Inc. (ALT) Under Investigation for Potential Securities Law ViolationsContact Levi & Korsinsky Today - ACCESS Newswire

Jul 28, 2025
pulisher
Jul 28, 2025

Altimmune Inc. stock daily chart insightsBuy Zone Strategy with Pattern Recognition - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

How Altimmune Inc. stock performs during market volatilityShort-Term Trade Setup with Forecast Insight - Newser

Jul 28, 2025
pulisher
Jul 27, 2025

Should I hold or sell Altimmune Inc. stock in 2025Unlock expert market analysis instantly - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What are analysts’ price targets for Altimmune Inc. in the next 12 monthsHigh-impact investment strategies - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Altimmune, Inc.ALT - WV News

Jul 27, 2025
pulisher
Jul 27, 2025

Altimmune Inc. Stock Chart Analysis: Bullish or Bearish Pattern FormingWatchlist Winner Update - Newser

Jul 27, 2025
pulisher
Jul 26, 2025

Altimmune, Inc. (NASDAQ:ALT) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World

Jul 26, 2025
pulisher
Jul 25, 2025

Altimmune Gears Up to Report Q2 Earnings: Here's What to Expect - The Globe and Mail

Jul 25, 2025
pulisher
Jul 25, 2025

Lost Money on Altimmune, Inc. (ALT)? Possible FraudContact Levi & Korsinsky Today - ACCESS Newswire

Jul 25, 2025
pulisher
Jul 25, 2025

What analysts say about Altimmune Inc. stockExceptional risk-adjusted gains - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 24, 2025

Levi & Korsinsky Investigating Whether Altimmune, Inc. (ALT) Misled InvestorsSecurities Law Violations Possible - ACCESS Newswire

Jul 24, 2025
pulisher
Jul 24, 2025

Altimmune: Potential Tough Road Ahead Amid Fierce Competition (Rating Downgrade) (ALT) - Seeking Alpha

Jul 24, 2025
pulisher
Jul 23, 2025

Altimmune Inc (ALT) Stock: A Year of Stock Market Dynamics - investchronicle.com

Jul 23, 2025
pulisher
Jul 23, 2025

Lost Investment in Altimmune, Inc. (ALT)? Levi & Korsinsky Launches Securities Fraud Investigation - ACCESS Newswire

Jul 23, 2025
pulisher
Jul 23, 2025

Is Altimmune Inc. a good long term investmentPowerful growth strategies - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What drives Altimmune Inc. stock priceConsistent triple-digit returns - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

Shareholders Alert: Investigation Into Altimmune, Inc. (ALT)Contact Levi & Korsinsky to Protect Your Rights - ACCESS Newswire

Jul 22, 2025
pulisher
Jul 22, 2025

Lost Money on Altimmune, Inc. (ALT)? Contact Levi & Korsinsky About Fraud Investigation - ACCESS Newswire

Jul 22, 2025
pulisher
Jul 21, 2025

Altimmune Inc. Stock Analysis and ForecastFree High-Return Strategy Alerts - Autocar Professional

Jul 21, 2025
pulisher
Jul 21, 2025

Levi & Korsinsky Reminds Altimmune, Inc. Investors of the Ongoing Investigation into Potential Violations of Securities LawsALT - ACCESS Newswire

Jul 21, 2025
pulisher
Jul 21, 2025

Investors in Altimmune, Inc. (ALT) Warned of Potential Securities FraudContact Levi & Korsinsky Today - Newsfile

Jul 21, 2025
pulisher
Jul 20, 2025

(ALT) Technical Pivots with Risk Controls - news.stocktradersdaily.com

Jul 20, 2025
pulisher
Jul 20, 2025

ALT ALERT: Ongoing Investigation Into Altimmune, Inc.Contact Levi & Korsinsky - ACCESS Newswire

Jul 20, 2025
pulisher
Jul 19, 2025

Securities Litigation as a Strategic Tool: Lessons from Altimmune's Legal Challenges and the Role of the Schall Law Firm - AInvest

Jul 19, 2025
pulisher
Jul 19, 2025

ALT Investors Have Opportunity to Join Altimmune, Inc. Fraud Investigation with the Schall Law Firm - Business Wire

Jul 19, 2025
pulisher
Jul 18, 2025

Did Altimmune, Inc. (ALT) Mislead Investors? Levi & Korsinsky Investigates - ACCESS Newswire

Jul 18, 2025
pulisher
Jul 15, 2025

What makes Altimmune Inc. stock price move sharplyFree Smart Money Stock Analysis - Newser

Jul 15, 2025
pulisher
Jul 14, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Altimmune, Inc. - GlobeNewswire Inc.

Jul 14, 2025
pulisher
Jul 14, 2025

OneDigital Investment Advisors LLC Sells 2,887 Shares of Altimmune, Inc. (NASDAQ:ALT) - Defense World

Jul 14, 2025
pulisher
Jul 14, 2025

Concurrent Investment Advisors LLC Purchases New Holdings in Altimmune, Inc. (NASDAQ:ALT) - Defense World

Jul 14, 2025
$77.38
price up icon 10.28%
$37.27
price up icon 0.57%
$105.00
price up icon 3.19%
$26.74
price down icon 2.59%
$111.48
price down icon 1.16%
biotechnology ONC
$305.74
price up icon 3.81%
자본화:     |  볼륨(24시간):